Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
$235.7M | -$0.05 | -0.64% | -89.46% | $4.25 |
|
BCPC
Balchem Corp.
|
$258.3M | $1.31 | 8.16% | 24.54% | $191.00 |
|
IOSP
Innospec, Inc.
|
$437.5M | $1.06 | -1.27% | -20.34% | $99.33 |
|
PZG
Paramount Gold Nevada Corp.
|
-- | -$0.02 | -- | -50% | $1.70 |
|
XPL
Solitario Resources Corp.
|
-- | -$0.01 | -- | -64.16% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
$3.09 | $4.25 | $238.6M | -- | $0.00 | 0% | 0.25x |
|
BCPC
Balchem Corp.
|
$157.14 | $191.00 | $5.1B | 34.40x | $0.96 | 0.61% | 5.06x |
|
IOSP
Innospec, Inc.
|
$78.12 | $99.33 | $1.9B | 98.17x | $0.87 | 2.19% | 1.09x |
|
PZG
Paramount Gold Nevada Corp.
|
$1.18 | $1.70 | $92.5M | -- | $0.00 | 0% | -- |
|
XPL
Solitario Resources Corp.
|
$0.64 | $1.50 | $58.2M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
34.99% | 1.301 | 143.29% | 2.07x |
|
BCPC
Balchem Corp.
|
11.7% | 0.403 | 3.54% | 1.54x |
|
IOSP
Innospec, Inc.
|
3.64% | 0.502 | 2.56% | 1.77x |
|
PZG
Paramount Gold Nevada Corp.
|
27.01% | 2.031 | 12.18% | 1.08x |
|
XPL
Solitario Resources Corp.
|
0.07% | 0.780 | 0.03% | 17.12x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
$29.3M | $22.8M | -14.41% | -22.14% | 9.46% | $21.2M |
|
BCPC
Balchem Corp.
|
$95.5M | $54.9M | 10.45% | 12.23% | 20.52% | $50.7M |
|
IOSP
Innospec, Inc.
|
$116.7M | $31.1M | -0.09% | -0.1% | 7.04% | $17.2M |
|
PZG
Paramount Gold Nevada Corp.
|
-$95.7K | -$1.5M | -25.69% | -34.36% | -- | -$1.1M |
|
XPL
Solitario Resources Corp.
|
-$18K | -$2M | -20.56% | -20.59% | -- | -$1.7M |
Balchem Corp. has a net margin of 5.9% compared to Alto Ingredients, Inc.'s net margin of 15.06%. Alto Ingredients, Inc.'s return on equity of -22.14% beat Balchem Corp.'s return on equity of 12.23%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
12.16% | $0.19 | $342.1M |
|
BCPC
Balchem Corp.
|
35.68% | $1.24 | $1.5B |
Alto Ingredients, Inc. has a consensus price target of $4.25, signalling upside risk potential of 43.1%. On the other hand Balchem Corp. has an analysts' consensus of $191.00 which suggests that it could grow by 21.94%. Given that Alto Ingredients, Inc. has higher upside potential than Balchem Corp., analysts believe Alto Ingredients, Inc. is more attractive than Balchem Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
1 | 0 | 0 |
|
BCPC
Balchem Corp.
|
1 | 1 | 0 |
Alto Ingredients, Inc. has a beta of 0.511, which suggesting that the stock is 48.89% less volatile than S&P 500. In comparison Balchem Corp. has a beta of 0.992, suggesting its less volatile than the S&P 500 by 0.809%.
Alto Ingredients, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Balchem Corp. offers a yield of 0.61% to investors and pays a quarterly dividend of $0.96 per share. Alto Ingredients, Inc. pays 2.15% of its earnings as a dividend. Balchem Corp. pays out 22.16% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
Alto Ingredients, Inc. quarterly revenues are $241M, which are smaller than Balchem Corp. quarterly revenues of $267.6M. Alto Ingredients, Inc.'s net income of $14.2M is lower than Balchem Corp.'s net income of $40.3M. Notably, Alto Ingredients, Inc.'s price-to-earnings ratio is -- while Balchem Corp.'s PE ratio is 34.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alto Ingredients, Inc. is 0.25x versus 5.06x for Balchem Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
0.25x | -- | $241M | $14.2M |
|
BCPC
Balchem Corp.
|
5.06x | 34.40x | $267.6M | $40.3M |
Innospec, Inc. has a net margin of 5.9% compared to Alto Ingredients, Inc.'s net margin of 2.92%. Alto Ingredients, Inc.'s return on equity of -22.14% beat Innospec, Inc.'s return on equity of -0.1%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
12.16% | $0.19 | $342.1M |
|
IOSP
Innospec, Inc.
|
26.41% | $0.52 | $1.4B |
Alto Ingredients, Inc. has a consensus price target of $4.25, signalling upside risk potential of 43.1%. On the other hand Innospec, Inc. has an analysts' consensus of $99.33 which suggests that it could grow by 27.16%. Given that Alto Ingredients, Inc. has higher upside potential than Innospec, Inc., analysts believe Alto Ingredients, Inc. is more attractive than Innospec, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
1 | 0 | 0 |
|
IOSP
Innospec, Inc.
|
2 | 0 | 0 |
Alto Ingredients, Inc. has a beta of 0.511, which suggesting that the stock is 48.89% less volatile than S&P 500. In comparison Innospec, Inc. has a beta of 0.931, suggesting its less volatile than the S&P 500 by 6.907%.
Alto Ingredients, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Innospec, Inc. offers a yield of 2.19% to investors and pays a quarterly dividend of $0.87 per share. Alto Ingredients, Inc. pays 2.15% of its earnings as a dividend. Innospec, Inc. pays out 109.37% of its earnings as a dividend. Alto Ingredients, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec, Inc.'s is not.
Alto Ingredients, Inc. quarterly revenues are $241M, which are smaller than Innospec, Inc. quarterly revenues of $441.9M. Alto Ingredients, Inc.'s net income of $14.2M is higher than Innospec, Inc.'s net income of $12.9M. Notably, Alto Ingredients, Inc.'s price-to-earnings ratio is -- while Innospec, Inc.'s PE ratio is 98.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alto Ingredients, Inc. is 0.25x versus 1.09x for Innospec, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
0.25x | -- | $241M | $14.2M |
|
IOSP
Innospec, Inc.
|
1.09x | 98.17x | $441.9M | $12.9M |
Paramount Gold Nevada Corp. has a net margin of 5.9% compared to Alto Ingredients, Inc.'s net margin of --. Alto Ingredients, Inc.'s return on equity of -22.14% beat Paramount Gold Nevada Corp.'s return on equity of -34.36%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
12.16% | $0.19 | $342.1M |
|
PZG
Paramount Gold Nevada Corp.
|
-- | -$0.06 | $43.2M |
Alto Ingredients, Inc. has a consensus price target of $4.25, signalling upside risk potential of 43.1%. On the other hand Paramount Gold Nevada Corp. has an analysts' consensus of $1.70 which suggests that it could grow by 44.07%. Given that Paramount Gold Nevada Corp. has higher upside potential than Alto Ingredients, Inc., analysts believe Paramount Gold Nevada Corp. is more attractive than Alto Ingredients, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
1 | 0 | 0 |
|
PZG
Paramount Gold Nevada Corp.
|
1 | 0 | 0 |
Alto Ingredients, Inc. has a beta of 0.511, which suggesting that the stock is 48.89% less volatile than S&P 500. In comparison Paramount Gold Nevada Corp. has a beta of 1.319, suggesting its more volatile than the S&P 500 by 31.91%.
Alto Ingredients, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Paramount Gold Nevada Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alto Ingredients, Inc. pays 2.15% of its earnings as a dividend. Paramount Gold Nevada Corp. pays out -- of its earnings as a dividend. Alto Ingredients, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Alto Ingredients, Inc. quarterly revenues are $241M, which are larger than Paramount Gold Nevada Corp. quarterly revenues of --. Alto Ingredients, Inc.'s net income of $14.2M is higher than Paramount Gold Nevada Corp.'s net income of -$4.3M. Notably, Alto Ingredients, Inc.'s price-to-earnings ratio is -- while Paramount Gold Nevada Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alto Ingredients, Inc. is 0.25x versus -- for Paramount Gold Nevada Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
0.25x | -- | $241M | $14.2M |
|
PZG
Paramount Gold Nevada Corp.
|
-- | -- | -- | -$4.3M |
Solitario Resources Corp. has a net margin of 5.9% compared to Alto Ingredients, Inc.'s net margin of --. Alto Ingredients, Inc.'s return on equity of -22.14% beat Solitario Resources Corp.'s return on equity of -20.59%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
12.16% | $0.19 | $342.1M |
|
XPL
Solitario Resources Corp.
|
-- | -$0.02 | $24.8M |
Alto Ingredients, Inc. has a consensus price target of $4.25, signalling upside risk potential of 43.1%. On the other hand Solitario Resources Corp. has an analysts' consensus of $1.50 which suggests that it could grow by 134.38%. Given that Solitario Resources Corp. has higher upside potential than Alto Ingredients, Inc., analysts believe Solitario Resources Corp. is more attractive than Alto Ingredients, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
1 | 0 | 0 |
|
XPL
Solitario Resources Corp.
|
2 | 0 | 0 |
Alto Ingredients, Inc. has a beta of 0.511, which suggesting that the stock is 48.89% less volatile than S&P 500. In comparison Solitario Resources Corp. has a beta of 0.440, suggesting its less volatile than the S&P 500 by 55.966%.
Alto Ingredients, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solitario Resources Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alto Ingredients, Inc. pays 2.15% of its earnings as a dividend. Solitario Resources Corp. pays out -- of its earnings as a dividend. Alto Ingredients, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Alto Ingredients, Inc. quarterly revenues are $241M, which are larger than Solitario Resources Corp. quarterly revenues of --. Alto Ingredients, Inc.'s net income of $14.2M is higher than Solitario Resources Corp.'s net income of -$1.9M. Notably, Alto Ingredients, Inc.'s price-to-earnings ratio is -- while Solitario Resources Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alto Ingredients, Inc. is 0.25x versus -- for Solitario Resources Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
ALTO
Alto Ingredients, Inc.
|
0.25x | -- | $241M | $14.2M |
|
XPL
Solitario Resources Corp.
|
-- | -- | -- | -$1.9M |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.